Tex. Insurance Code § 1369.357
APPEAL FROM MAXIMUM ALLOWABLE COST PRICE DETERMINATION
Texas · Texas Insurance Code · Status: effective
Cite this
- Citation
- Tex. Insurance Code § 1369.357, APPEAL FROM MAXIMUM ALLOWABLE COST PRICE DETERMINATION, Texas, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/682245
- Permanent ID
ys:prov:682245@1- SHA-256
429970dafd131db677075776cf15bd47267381327734569e4d72fc2569475b16
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) A health benefit plan issuer or pharmacy benefit manager must provide in the contract with each pharmacist or pharmacy a procedure for the pharmacist or pharmacy to appeal a maximum allowable cost price of a drug on or before the 10th day after the date a pharmacy benefit claim for the drug is made.
(b) The health benefit plan issuer or pharmacy benefit manager shall respond to an appeal described by Subsection (a) in a documented communication not later than the 10th day after the date the appeal is received by the health benefit plan issuer or pharmacy benefit manager.
(c) If the appeal is successful, the health benefit plan issuer or pharmacy benefit manager shall:
(1) adjust the maximum allowable cost price that is the subject of the appeal effective on the day after the date the appeal is decided;
(2) apply the adjusted maximum allowable cost price to all similarly situated pharmacists and pharmacies as determined by the health benefit plan issuer or pharmacy benefit manager; and
(3) allow the pharmacist or pharmacy that succeeded in the appeal to reverse and rebill the pharmacy benefit claim giving rise to the appeal.
(d) If the appeal is not successful, the health benefit plan issuer or pharmacy benefit manager shall disclose to the pharmacist or pharmacy:
(1) each reason the appeal is denied; and
(2) the national drug code number from the national or regional wholesalers from which the drug is generally available for purchase by pharmacists and pharmacies in this state at the maximum allowable cost price that is the subject of the appeal.